Danggui Shaoyao Powder improves inflammatory response in rats with nonalcoholic fatty liver disease induced by high-fat diet by regulating the Sirt1/NF-κB signaling pathway

Wang Jing; Zhang Zhiyu; Yu Mingxia; Ye Ke; Yu Qingqing; Ye Weijia; Leng Xiuru; Wang Weiwei

doi:10.13406/j.cnki.cyxb.003261

您当前的位置：

首页 >

文章列表页 >

Danggui Shaoyao Powder improves inflammatory response in rats with nonalcoholic fatty liver disease induced by high-fat diet by regulating the Sirt1/NF-κB signaling pathway

Basic research | 更新时间：2025-10-21

- Danggui Shaoyao Powder improves inflammatory response in rats with nonalcoholic fatty liver disease induced by high-fat diet by regulating the Sirt1/NF-κB signaling pathway
- Journal of Chongqing Medical University Vol. 48, Issue 6, Pages: 656-661(2023)
- 作者机构：
  
  宿州学院生物与食品工程学院药物药理研究中心，宿州 234000
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003261
  CLC： R285.5
- Received：26 January 2023，
  
  Revised：2023-03-07，
  
  Accepted：05 May 2023，
  
  Published：28 June 2023
- 稿件说明：
移动端阅览
王静,张止雨,余明霞,等.当归芍药散通过调节Sirt1/NF-κB信号通路改善高脂饮食诱导大鼠非酒精性脂肪肝炎症反应[J].重庆医科大学学报,2023,48(6):656-661.

Wang Jing,Zhang Zhiyu,Yu Mingxia,et al.Danggui Shaoyao Powder improves inflammatory response in rats with nonalcoholic fatty liver disease induced by high-fat diet by regulating the Sirt1/NF-κB signaling pathway[J].Journal of Chongqing Medical University,2023,48(6):656-661.
王静,张止雨,余明霞,等.当归芍药散通过调节Sirt1/NF-κB信号通路改善高脂饮食诱导大鼠非酒精性脂肪肝炎症反应[J].重庆医科大学学报,2023,48(6):656-661. DOI： 10.13406/j.cnki.cyxb.003261.

Wang Jing,Zhang Zhiyu,Yu Mingxia,et al.Danggui Shaoyao Powder improves inflammatory response in rats with nonalcoholic fatty liver disease induced by high-fat diet by regulating the Sirt1/NF-κB signaling pathway[J].Journal of Chongqing Medical University,2023,48(6):656-661. DOI： 10.13406/j.cnki.cyxb.003261.

摘要

目的

研究当归芍药散治疗高脂饮食（high-fat diet，HFD）诱导的大鼠非酒精性脂肪性肝病（nonalcoholic fatty liver disease，NAFLD）炎症反应的作用机制。

方法

将大鼠随机分为5组：正常组、HFD组、阿伐他丁组、当归芍药散低剂量组、当归芍药散高剂量组。大鼠给予高脂肪饲料（59.3%脂肪饲料）6周，正常组大鼠同时给予正常饲料。从第5周开始，阿伐他丁组大鼠灌胃给予25 mg/kg阿伐他丁2周，当归芍药散低剂量组大鼠灌胃给予12.9 g/kg当归芍药散2周，当归芍药散高剂量组大鼠灌胃给予25.8 g/kg当归芍药散2周，检测大鼠血清丙氨酸氨基转移酶（alanine aminotransferase，ALT）、天冬氨酸氨基转移酶（aspartate aminotransferase，AST）、甘油三酯（triglyceride，TG）、胆固醇（cholesterol，TC）、血清细胞因子水平。同时检测大鼠肝脏沉默信息调节因子1（sirtuin 1，Sirt1）/核转录因子-κB（nuclear factor kappa-B，NF-κB）信号通路蛋白表达。

结果

与模型组比较，当归芍药散能显著降低血清ALT、AST、TG、TC、血清细胞因子水平，改善肝脏组织病理学改变。此外，显著增加大鼠肝脏Sirt1表达，抑制肝脏NF-κB蛋白表达。

结论

当归芍药散通过Sirt1/NF-κB通路治疗HFD大鼠NAFLD。

Abstract

Objective

To investigate the mechanism of action of Danggui Shaoyao Powder in the treatment of inflammatory response in rats with nonalcoholic fatty liver disease（NAFLD） induced by high-fat diet（HFD）.

Methods

Rats were randomly divided into normal group，HFD group， avastatin group，Danggui Shaoyao Powder low-dose group，and Danggui Shaoyao Powder high-dose group. The rats were given HFD（containing 59.3% fat） for 6 weeks，while the rats in the normal group were given normal diet. Since week 5，rats in the avastatin group were given 25 mg/kg of Avastatin by gavage for 2 weeks， while rats in the low-dose Danggui Shaoyao powder group were given 12.9 g/kg of Danggui Shaoyao powder by gavage for 2 weeks， and rats in the high-dose Danggui Shaoyao powder group were given 25.8 g/kg of Danggui Shaoyao powder by gavage for 2 weeks，and the serum levels of alanine aminotransferase（ALT），aspartate aminotransferase（AST），triglyceride（TG），cholesterol（TC），and cytokines were measured. Meanwhile，the expression levels of the sirtuin 1（Sirt1）/nuclear factor kappa-B（NF-κB） signaling pathway proteins in rat liver were also measured.

Results

Compared with the model group，Danggui Shaoyao Powder significantly reduced the serum levels of ALT，AST，TG，TC，and cytokines and improved the pathological changes of the liver. In addition，it significantly increased the expression of Sirt1 and inhibited the expression of NF-κB in rat liver.

Conclusion

Danggui Shaoyao Powder exerts a therapeutic effect on rats with NAFLD induced by HFD through the Sirt1/NF-κB pathway.

关键词

Keywords

references

Weiß J ， Rau M ， Geier A . Non-alcoholic fatty liver disease [J ] . Deutsches Ärzteblatt Int ， 2014 ， 111 （ 26 ）： 447 - 452 .

Videla LA ， Pettinelli P . Misregulation of PPAR functioning and its pathogenic consequences associated with nonalcoholic fatty liver disease in human obesity [J ] . PPAR Res ， 2012 ， 2012 ： 107434 .

Lee J ， Kim Y ， Friso S ， et al . Epigenetics in non-alcoholic fatty liver disease [J ] . Mol Aspects Med ， 2017 ， 54 ： 78 - 88 .

Jornayvaz FR ， Samuel VT ， Shulman GI . The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome [J ] . Annu Rev Nutr ， 2010 ， 30 ： 273 - 290 .

Liu ZX ， Dou WJ ， Ni Z ， et al . Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet [J ] . Mol Med Rep ， 2016 ， 14 （ 2 ）： 1323 - 1331 .

Choi YH ， Bae JK ， Chae HS ， et al . α-mangostin regulates hepatic steatosis and obesity through SirT1-AMPK and PPARγ pathways in high-fat diet-induced obese mice [J ] . J Agric Food Chem ， 2015 ， 63 （ 38 ）： 8399 - 8406 .

Oliveira Andrade JM ， Paraíso AF ， Garcia ZM ， et al . Cross talk between angiotensin-（1-7）/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice [J ] . Peptides ， 2014 ， 55 ： 158 - 165 .

Zain SM ， Mohamed Z ， Mahadeva S ， et al . Does polymorphism in patatin-like phospholipase 3 gene（PNPLA3）confer risk of nonalcoholic fatty liver disease（NAFLD）in multiethnic Malaysian population? [J ] . Drug Metab Rev ， 2011 ， 43 （ 1 ）： 56 - 57 .

Baratta F ， Pastori D ， Tozzi G ， et al . Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease [J ] . Liver Int ， 2019 ， 39 （ 12 ）： 2301 - 2308 .

Ezquerro S ， Méndez-Giménez L ， Becerril S ， et al . Acylated and desacyl ghrelin are associated with hepatic lipogenesis，β-oxidation and autophagy：role in NAFLD amelioration after sleeve gastrectomy in obese rats [J ] . Sci Rep ， 2016 ， 6 ： 39942 .

Liu J ， Wang PP ， Douglas SL ， et al . Impact of high-fat，low-carbohydrate diet on myocardial substrate oxidation，insulin sensitivity，and cardiac function after ischemia-reperfusion [J ] . Am J Physiol Heart Circ Physiol ， 2016 ， 311 （ 1 ）： H1 - H10 .

Plubell DL ， Wilmarth PA ， Zhao YQ ， et al . Extended multiplexing of tandem mass tags（TMT） labeling reveals age and high fat diet specific proteome changes in mouse epididymal adipose tissue [J ] . Mol Cell Proteomics ， 2017 ， 16 （ 5 ）： 873 - 890 .

Karbaschi R ， Zardooz H ， Khodagholi F ， et al . Maternal high-fat diet intensifies the metabolic response to stress in male rat offspring [J ] . Nutr Metab ， 2017 ， 14 ： 20 .

Priscilla DH ， Jayakumar M ， Thirumurugan K . Flavanone naringenin：an effective antihyperglycemic and antihyperlipidemic nutraceutical agent on high fat diet fed streptozotocin induced type 2 diabetic rats [J ] . J Funct Foods ， 2015 ， 14 ： 363 - 373 .

Chen J ， Li J ， Wang J ， et al . Association of serum VLDL level with hyperhomocysteinemia in hypertensive patients：a cross-sectional study [J ] . Clin Exp Hypertens ， 2021 ， 43 （ 1 ）： 26 - 33 .

Park HS ， Song JW ， Park JH ， et al . TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation [J ] . Autophagy ， 2021 ， 17 （ 9 ）： 2549 - 2564 .

Ren YY ， Gu YH ， Wang W ， et al . Expression of the significance of silent information regulator type-1 in angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosis [J ] . Cell Cycle ， 2016 ， 15 （ 12 ）： 1545 - 1551 .

Li Y ， Xu SQ ， Giles A ， et al . Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver [J ] . FASEB J ， 2011 ， 25 （ 5 ）： 1664 - 1679 .

Zhang HS ， Chen XY ， Wu TC ， et al . MiR-34a is involved in Tat-induced HIV-1 long terminal repeat（LTR）transactivation through the SirT1/NF-κB pathway [J ] . FEBS Lett ， 2012 ， 586 （ 23 ）： 4203 - 4207 .

dela Peña A ， Leclercq I ， Field J ， et al . NF-κB activation，rather than TNF，mediates hepatic inflammation in a murine dietary model of steatohepatitis [J ] . Gastroenterology ， 2005 ， 129 （ 5 ）： 1663 - 1674 .

Wang XN ， Zhang R ， She ZG ， et al . Interferon regulatory factor 3 constrains IKKβ/NF-κB signaling to alleviate hepatic steatosis and insulin resistance [J ] . Hepatology ， 2014 ， 59 （ 3 ）： 870 - 885 .

Song M ， Meng LK ， Liu XX ， et al . Feprazone prevents free fatty acid（FFA）-induced endothelial inflammation by mitigating the activation of the TLR4/MyD88/NF-κB pathway [J ] . ACS Omega ， 2021 ， 6 （ 7 ）： 4850 - 4856 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of Danggui Shaoyao powder regulating TLR4/MyD88/NF-κB signaling pathway to reduce colonic injury in ulcerative colitis rats

Detection rate of nonalcoholic fatty liver disease and its influencing factors: a study based on the physical examination data of 54 067 cases in Western Chongqing，China

Mediating role of TYG-BMI in vitamin D and nonalcoholic fatty liver disease

Effects of p38 mitogen-activated protein kinase in rats with nonalcoholic fatty liver disease

Related Author

Du Xiaowei

Song Xiaoxue

Yan Lili

Meng Fanjia

Zhang Wenwei

Feng Guibo

Zhang Yu

Qin Yueqi

Related Institution

School of Pharmacy，Heilongjiang University of Chinese Medicine

Experimental and Practical Training Center Heilongjiang University of Chinese Medicine

Information Center，Yongchuan Hospital Affiliated to Chongqing Medical University

General Medicine Department，Yongchuan Hospital Affiliated to Chongqing Medical University

Department of Endocrinology， Hebei General Hospital

⁰